பயோஅனாலிசிஸ் & பயோமெடிசின் ஜர்னல்

Preclinical Toxicity Evaluation of Quassia amara Extract with Potential Antimycobacterial Activity

Abstract

Vinicius P. Arantes, Guilherme L. Emerick, Lais Silva Fernandes, Ivan O. Pereira and Georgino H. DeOliveira

This study aimed to evaluate the oral acute and sub chronic toxicity of Quassia amara (Q. amara) extract.
For the acute toxicity study, six male and six female rats received 2000 and 5000 mg/kg Q. amara extract. Rats were observed for 14 days; after sacrifice, liver, kidneys, lung, spleen and heart were submitted to macroscopic analysis. No death occurred and just the liver presented significant difference compared to the control group. For subchronic toxicity, eight groups of 6 male and 6 female rats received 200, 400 and 800 μg/mL of extract of Q. amara. Prothrombin time, bilirubin, urea, creatinine and gamma glutamyl transpeptidase (γ-GT), aspartate transaminase (AST), alanine transaminase (ALT) and alkaline phosphatase (ALP) were used as markers of renal and hepatobiliary function, respectively. The male showed a slight rise in serum bilirubin and creatinine and the female slight rise of AST, ALT and ALP activities. The urinalyses (pH, density, glucose and leukocytes) showed no change relative to the control. The NOAEL of 35 mg/kg and RfD 0.35 mg/kg/day encourage us to isolate the active principles in order to discover which molecules of this extract showed better antimycobacterial activity.